Abstract: The invention relates to a method for manufacturing a pellet in a pellet mill, which method comprises the steps of (A) pressing a mixture for compaction by a roller through a nozzle to obtain a strand, and (B) comminuting the strand to obtain the pellet, wherein the mixture for compaction comprises (i) 87 to 97 wt. % of a polymer stabilizer mixture polymer stabilizer mixture, which comprises the polymer stabilizers (i-1) 21 to 29 wt. % of tris(2,4-ditert-butylphenyl) phosphite (CAS-No. 31570-04-4), (i-2) 21 to 29 wt. % of tetrakis-[3-(3,5-ditert-butyl-4-hydroxy-phenyl)-propionyloxymethyl]methane (CAS-No. 6683-19-8), (i-3) 8 to 12 wt. % of a C16-C18 fatty acid calcium salt, (i-4) 36 to 44 wt. % of a calcium oxide, and wt. % of the polymer stabilizers (i-1), (i-2), (i-3) and (i-4) are based on the weight of the polymer stabilizer mixture, and (ii) 3 to 13 wt. % of a processing aid, which is a propylene-ethylene copolymer and which possesses a melting enthalpy below 100 J/g at 101.32 kPa.

Abstract: The invention relates to a method for manufacturing a pellet in a pellet mill, which method comprises the steps of (A) pressing a mixture for compaction by a roller through a nozzle to obtain a strand, and (B) comminuting the strand to obtain the pellet, wherein the mixture for compaction comprises (i) 87 to 97 wt. % of a polymer stabilizer mixture polymer stabilizer mixture, which comprises the polymer stabilizers (i-1) 35 to 45 wt. % of tris(2,4-ditert-butylphenyl) phosphite (CAS-No. 31570-04-4), (i-2) 15 to 25 wt. % of tetrakis-[3-(3,5-ditert-butyl-4-hydroxy-phenyl)-propionyloxymethyl]methane (CAS-No. 6683-19-8), (i-3) 35 to 45 wt. % of a C16-C18 fatty acid calcium salt, and wt. % of the polymer stabilizers (i-1), (i-2) and (i-3) are based on the weight of the polymer N stabilizer mixture, and (ii) 3 to 13 wt. % of a processing aid, which is a propylene-ethylene copolymer and which possesses a melting enthalpy below 100 J/g at 101.32 kPa.

Abstract: A computer-implemented method can be used for controlling sorting of plastic compounds. The method involves providing a computer-based database containing entries on a plurality of markers each identifying a specific plastic compound; receiving scan data from a sample of a plastic compound; identifying a marker in the sample of the plastic compound based on the received scan data and the plurality of markers of the database; and sorting of plastic compounds based on the identified marker of the sample of the plastic compound.

Abstract: A process for esterification and/or trans-esterification, uses an acid as catalyst in the presence of an anionic surfactant.

Abstract: Described herein is an excitation emission matrix (EEM) spectrometer and method, comprising a multiplexer that encodes excitation light produced by at least one excitation light source; and a demultiplexer that decodes encoded light emitted from a sample, and produces an output indicative of a characteristic of the sample. Embodiments are described wherein the multiplexer and the demultiplexer may comprise FDM or OFDM, and wherein both the excitation light and the emitted light may be encoded using a DMA or a SLM. In some embodiments the same DMA or SLM may be used to encode the excitation light and the emitted light. In some embodiments excitation light may be encoded using a Walsh function, or the excitation light may be encoded using a Walsh function and the emitted light may be decoded using an inverse Hadamard transformation.

Abstract: Compounds of the formulae and selected hindered nitroxyl, hydroxylamine and hydroxylamine salt compounds such as the compound of the formula wherein G1 is hydrogen; C1-C22alkyl; C1-C22alkylthio; C2-C22alkylthioalkyl; C5-C7cycloalkyl; phenyl; C7-C9-phenylalkyl; or SO3M; G2 is C1-C22alkyl; C5-C7cycloalkyl; phenyl; or C7-C9-phenylalkyl; E is oxyl or hydroxyl; V is —O—; or —NH—; a is 0 or 1 or 2; b, c and d and g are each independently of one another 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently of one another an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G3 are as defined in claim 1; G4 and G5 are each independently of the other hydrogen; or C1-C22alkyl; exhibit marked antiinflammatory action.

Abstract: Disclosed is the use of benzotropolone derivatives of formula wherein R1, R2 and R7 independently from each other are hydrogen; C1-C3alkyl; or COR8; R3 is hydrogen; or COOR9 R4 is hydrogen; or C1-C3alkyl; R5 is hydrogen; hydroxy; C1-C3-alkoxy; or —O—(CO)—R10; R6 is hydrogen; C1-C3alkyl; or COR8; or R5 and R6 together may form a five or six membered ring; or R6 and R7 together form a five or six membered ring; and R8, R9, R10 independently of each other are C1-C30alkyl; for protecting body-care and household products from photolytic and oxidative degradation.

Abstract: Described herein is an excitation emission matrix (EEM) spectrometer and method, comprising a multiplexer that encodes excitation light produced by at least one excitation light source; and a demultiplexer that decodes encoded light emitted from a sample, and produces an output indicative of a characteristic of the sample. Embodiments are described wherein the multiplexer and the demultiplexer may comprise FDM or OFDM, and wherein both the excitation light and the emitted light may be encoded using a DMA or a SLM. In some embodiments the same DMA or SLM may be used to encode the excitation light and the emitted light. In some embodiments excitation light may be encoded using a Walsh function, or the excitation light may be encoded using a Walsh function and the emitted light may be decoded using an inverse Hadamard transformation.

Abstract: Disclosed is the use of benzotropolone derivatives of formula wherein R1, R2 and R7 independently from each other are hydrogen; C1-C3alkyl; or COR8; R3 is hydrogen; or COOR9 R4 is hydrogen; or C1-C3alkyl; R5 is hydrogen; hydroxy; C1-C3-alkoxy; or —O—(CO)—R10; R6 is hydrogen; C1-C3alkyl; or COR8; or R5 and R6 together may form a five or six membered ring; or R6 and R7 together form a five or six membered ring; and R8, R9, R10 independently of each other are C1-C30alkyl; for protecting body-care and household products from photolytic and oxidative degradation.

Abstract: Described is the use of specific merocyanine derivatives for protecting body-care and household products from photolytic and oxidative degradation. These compounds perform outstanding UV absorber properties.

Abstract: Disclosed is the use of benzotropolone derivatives of formula (1), wherein R1, R2 and R7 independently from each other are hydrogen; C1-C3alkyl; or COR8; R3 is hydrogen; or COOR9 R4 is hydrogen; or C1-C3alkyl; R5 is hydrogen; hydroxy; C1-C3-alkoxy; or -0-(CO)—R10; R6 is hydrogen; C1-C3alkyl; or COR8; or R5 and R6 together may form a five or six membered ring; or R6 and R7 together form a five or six membered ring; and R8, R9, R10 independently of each other are C1-C30alkyl; for protecting body-care and household products from photolytic and oxidative degradation.

Abstract: Described is the use of specific lactone compounds for protecting body-care and household products from photolytic and oxidative degradation. These compounds perform outstanding antioxidant properties.

Abstract: The present invention relates to the use of a stabilizing composition comprising (a) an effective stabilizing amount of at least one merocyanine derivative having an absorption maximum of 350 to 400 nm, and (b) at least one UV filter selected from benzotriazole derivatives; and optionally (c) at least one excited state quencher; for the protection of body care and household products against the deleterious effects of light, heat and oxygen.

Abstract: The present invention relates to the use of a stabilizing composition comprising (a) an effective stabilizing amount of at least one merocyanine derivative having an absorption maximum of 350 to 400 nm, and (b) at least one UV filter selected from benzotriazole derivatives; and optionally (c) at least one excited state quencher; for the protection of body care and household products against the deleterious effects of light, heat and oxygen.

Abstract: Compounds of the formulae and selected hindered nitroxyl, hydroxylamine and hydroxylamine salt compounds such as the compound of the formula wherein G1 is hydrogen; C1-C22alkyl; C1-C22alkylthio; C2-C22alkylthioalkyl; C5-C7cycloalkyl; phenyl; C7-C9-phenylalkyl; or SO3M; G2 is C1-C22alkyl; C5-C7cycloalkyl; phenyl; or C7-C9-phenylalkyl; E is oxyl or hydroxyl; V is —O—; or —NH—; a is 0 or 1 or 2; b, c and d and g are each independently of one another 0 or 1; e is an integer from 1 to 4; f, m, n and p are each independently of one another an integer from 1 to 3; q is 0 or an integer from 1 to 3; Q, T and G3 are as defined in claim 1; G4 and G5 are each independently of the other hydrogen; or C1-C22alkyl; exhibit marked antiinflammatory action.

Abstract: The invention relates to a measuring arrangement for an optical spectrometer, in particular a photon density wave spectrometer, having a measuring chamber, which can be loaded with a sample to be measured, and a coupling-in/coupling-out device which is configured to receive excitation light from a light source and couple it into the sample to be measured in the measuring chamber and to receive measuring light formed in the sample to be measured on account of the excitation light which has been coupled in and to emit said measuring light to a detection device, wherein the coupling-in/coupling-out device has an optical switching device and a plurality of light guide elements which couple to the latter, have a respective optical waveguide and can be connected according to at least one selectable measuring configuration using the optical switching device in order to couple in the excitation light and receive the measuring light according to the at least one selectable measuring configuration, and wherein outputs

Abstract: Disclosed is the use of benzotropolone derivatives of formula (1), wherein R1, R2 and R7 independently from each other are hydrogen; C1-C3alkyl; or COR8; R3 is hydrogen; or COOR9 R4 is hydrogen; or C1-C3alkyl; R5 is hydrogen; hydroxy; C1-C3-alkoxy; or -0-(CO)—R10; R6 is hydrogen; C1-C3alkyl; or COR8; or R5 and R6 together may form a five or six membered ring; or R6 and R7 together form a five or six membered ring; and R8, R9, R10 independently of each other are C1-C30alkyl; for protecting body-care and household products from photolytic and oxidative degradation.

Abstract: The present invention relates to the use of a stabilizing composition comprising (a) an effective stabilizing amount of at least one merocyanine derivative having an absorption maximum of 350 to 400 nm, and (b) at least one UV filter selected from benzotriazole derivatives; and optionally (c) at least one excited state quencher; for the protection of body care and household products against the deleterious effects of light, heat and oxygen.

Abstract: The invention relates to a process for the treatment of particles using a plasma torch and to the particles obtainable by the process. The particles so obtainable may be incorporated into coatings, plastics, paints, printing inks, ceramics, glasses or personal care products.

Abstract: Described is the use of specific lactone compounds for protecting body-care and household products from photolytic and oxidative degradation. These compounds perform outstanding antioxidant properties.